Abstract
TNFRSF17 is preferentially expressed in mature B lymphocytes, and may be important for the development of B cells. TNFRSF17 is selected as a candidate susceptibility gene to IBD pathogenesis by our cDNA microarray analysis, and we showed the specific expression of TNFRSF17 in resting and activated CD19+ cells obtained from human blood. We identified four SNPs (g-1729G>A, g.2295T>C, g.2445G>A and g.2493G>A) and one variation site (g.894delT) in the TNFRSF17 gene using direct sequencing analysis. In addition, the association of the genotype and allelic frequencies of these SNPs was studied in healthy controls and in patients with ulcerative colitis (UC) or irritable bowel syndrome (IBS). Although, the genotype and allelic frequencies of these SNPs, in the UC and IBS patients, were not significantly different from those in the healthy controls, the distribution of the AAG, GGA, AGG and AAA haplotypes, of the SNPs (g.-1729G>A, g.2445G> A and g.2493G>A) associated with the TNFRSF17 gene, in the UC patients, were notably different from those of the healthy controls (P = 0.002, 0.002, 4.7E-4 and 3.3E-6, respectively). Moreover, the frequencies of the AAG, AGG, GAG and GAA haplotypes were significantly different in the IBS patients compared to the healthy controls (P = 4.2E-5, 4.4E-17, 1.8E-22 and 1.6E-10, respectively). These results suggest that the haplotypes of the TNFRSF17 polymorphisms might be associated with UC and IBS susceptibility.
Similar content being viewed by others
References
Ahmad, T., Tamboli, C.P., Jewell, D., and Colombel, J.F. (2004). Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 126, 1533–1549.
Andrews, C.N., and Shaffer, E.A. (2004). Simmering innards: does irritable bowel syndrome have an immunological basis? Can. J. Gastroenterol. 18, 601–603.
Blumberg, R.S., Saubermann, L.J., and Strober, W. (1999). Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11, 648–656.
Bossen, C., and Schneider, P. (2006). BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 18, 263–275.
Cavanaugh, J. (2001). International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am. J. Hum. Genet. 68, 1165–1171.
Chae, S.C., Shim, S.C., and Chung, H.T. (2009). Association of TBX21 polymorphisms in a Korean population with rheumatoid arthritis. Exp. Mol. Med. 41, 33–41.
Collins, S.M., Piche, T., and Rampal, P. (2001). The putative role of inflammation in the irritable bowel syndrome. Gut 49, 743–745.
Day, E.S., Cachero, T.G., Qian, F., Sun, Y., Wen, D., Pelletier, M., Hsu, Y.M., and Whitty, A. (2005). Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry 44, 1919–1931.
Fiocchi, C. (1998). Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115, 182–205.
Forbes, A. (2003). Clinical presentation and diagnosis of Crohn’s disease, J. Satsangi, and L.R. Sutherland, eds. (New York, USA: Churchill Livingstone), pp. 183–189.
Fuss, I.J., Neurath, M., Boirivant, M., Klein, J.S., de la Motte, C., Strong, S.A., Fiocchi, C., and Strober, W. (1996). Disparate CD4+ lamina propria (LP) lymphocyte secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN gamma, whereas, ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157, 1261–1270.
Hahne, M., Kataoka, T., Schröter, M., Hofmann, K., Irmler, M., Bodmer, J.L., Schneider, P., Bornand, T., Holler, N., French, L.E., et al. (1998). APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188, 1185–1190.
Hampe, J., Cuthbert, A., Croucher, P.J., Mirza, M.M., Mascheretti, S., Fisher, S., Frenzel, H., King, K., Hasselmeyer, A., MacPherson, A.J., et al. (2001). Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 357, 1925–1928.
Hampe, J., Shaw, S.H., Saiz, R., Leysens, N., Lantermann, A., Mascheretti, S., Lynch, N.J., MacPherson, A.J., Bridger, S., van Deventer, S., et al. (1999). Linkage of inflammatory bowel disease to human chromosome 6p. Am. J. Hum. Genet. 65, 1647–1655.
Hugot, J.P., Laurent-Puig, P., Gower-Rousseau, C., Olson, J.M., Lee, J.C., Beaugerie, L., Naom, I., Dupas, J.L., Van Gossum, A., Orholm, M., et al. (1996). Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 379, 821–823.
Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.P., Belaiche, J., Almer, S., Tysk, C., O’Morain, C.A., Gassull, M., et al. (2001). Association of NOD2 leucinerich repeat variants with susceptibility to Crohn’s disease. Nature 411, 599–603.
Jin, E.H., Shim, S.C., Kim, H.G., Chae, S.C., and Chung, H.T. (2009). Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders. Exp. Mol. Med. 41, 354–361.
Laabi, Y., Gras, M.P., Carbonnel, F., Brouet, J.C., Berger, R., Larsen, C.J., and Tsapis, A. (1992). A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by at (4;16)(q26;p13) translocation in a malignant T cell lymphoma. EMBO J. 11, 3897–3904.
Lawrance, I.C., Fiocchi, C., and Chakravarti, S. (2001). Ulcerative colitis and Crohn’s disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum. Mol. Genet. 10, 445–456.
Locksley, R.M., Killeen, N., and Lenardo, M.J. (2001). The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487–501.
Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F., and Spiller, R.C. (2006). Functional bowel disorders. Gastroenterology 130, 1480–1491.
Mackay, F., and Browning, J.L. (2002). BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2, 465–475.
Moore, P.A., Belvedere, O., Orr, A., Pieri, K., LaFleur, D.W., Feng, P., Soppet, D., Charters, M., Gentz, R., Parmelee, D., et al. (1999). BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260–263.
O’Connor, B.P., Raman, V.S., Erickson, L.D., Cook, W.J., Weaver, L.K., Ahonen, C., Lin, L.L., Mantchev, G.T., Bram, R.J., and Noelle, R.J. (2004). BCMA is essential for the survival of longlived bone marrow plasma cells. J. Exp. Med. 199, 91–98.
Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R.H., et al. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411, 603–606.
Park, Y.R., Choi, S.C., Lee, S.T., Kim, K.S., Chae, S.C., and Chung, H.T. (2005). The association of eotaxin-2 and eotaxin-3 gene polymorphisms in a Korean population with ulcerative colitis. Exp. Mol. Med. 37, 553–558.
Parkes, M., Barmada, M.M., Satsangi, J., Weeks, D.E., Jewell, D.P., and Duerr, R.H. (2000). The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease. Am. J. Hum. Genet. 67, 1605–1610.
Phillips, T.A., Ni, J., and Hunt, J.S. (2003). Cell-specific expression of B lymphocyte- (APRIL. BLyS) and Th2- (CD30L/CD153) promoting tumor necrosis factor superfamily ligands in human placentas. J. Leukoc. Biol. 74, 81–87.
Podolsky, D.K. (2002). Inflammatory bowel disease. N. Engl. J. Med. 347, 417–429.
Sashio, H., Tamura, K., Ito, R., Yamamoto, Y., Bamba, H., Kosaka, T., Fukui, S., Sawada, K., Fukuda, Y., Tamura, K., et al. (2002). Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn’s disease, respectively. Immunogenetics 53, 1020–1027.
Schneider, P., MacKay, F., Steiner, V., Hofmann, K., Bodmer, J.L., Holler, N., Ambrose, C., Lawton, P., Bixler, S., Acha-Orbea, H., et al. (1999). BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 747–1756.
Shin, H.D., Jeon, J.F., Park, B.L., Bae, J.S., Nam, H.Y., Shim, S.M., Park, K.S., and Han, B.G. (2008). Novel promoter polymorphism in RUNX2 is associated with serum triglyceride level. Mol. Cells 26, 459–461.
Smirnova, S., Andrade-Oliveia, V., and Gerbase-DeLima, M. (2008). Identification of new splice variants of the genes BAFF and BCMA. Mol. Immunol. 45, 1179–1183.
Song, J.H., Choi, S.C., Lee, S.T., Yoon, K.S., Chae, S.C., and Chung, H.T. (2004). The exon 4 variations of Tim-1 gene is not associated with allergic rhinitis and ulcerative colitis in Koreans. Korean J. Genetics 26, 193–197.
Spiller, R.C. (2003). Postinfectious irritable bowel syndrome. Gastroenterology 124, 1662–1671.
Spiller, R.C. (2004). Inflammation as a basis for functional GI disorders. Best Pract. Res. Clin. Gastroenterol. 18, 641–661.
Talley, N.J., and Spiller, R. (2002). Irritable bowel syndrome: a little understood organic bowel disease? Lancet 360, 555–564.
Thompson, J.S., Schneider, P., and Kalled, S.L. (2000). BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 192, 129–135.
Thompson, J.S., Bixler, S.A., Qian, F., Vora, K., Scott, M.L., Cachero, T.G., Hession, C., Schneider, P., Sizing, I.D., Mullen, C., et al. (2001). BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293, 2108–2111.
Travis, S., and Jewell, D.P. (2003). Ulcerative colitis: clinical presentation and diagnosis, J. Satsangi, and L.R. Sutherland, eds. (New York, USA: Churchill Livingstone), pp. 169–182.
van Heel, D.A., Fisher, S.A., Kirby, A., Daly, M.J., Rioux, J.D., and Lewis, C.M. (2004). Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum. Mol. Genet. 13, 763–770.
Warner, E.E., and Dieckgraefe, B.K. (2002). Application of genomewide gene expression profiling by high-density DNA arrays to the treatment and study of inflammatory bowel disease. Inflamm. Bowel. Dis. 8, 140–157.
Wu, Y., Bressette, D., Carrell, J.A., Kaufman, T., Feng, P., Taylor, K., Gan, Y., Cho, Y.H., Garcia, A.D., Gollatz, E., et al. (2000). Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J. Biol. Chem. 275, 35478–35485.
Yang, Y.H., Dudoit, S., Luu, P., Lin, D.M., Peng, V., Ngai, J., and Speed, T.P. (2002). Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Chae, SC., Yu, JI., Oh, GJ. et al. Identification of single nucleotide polymorphisms in the TNFRSF17 gene and their association with gastrointestinal disorders. Mol Cells 29, 21–28 (2010). https://doi.org/10.1007/s10059-010-0002-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-010-0002-6